Publication list
2023
Juhász, L.,
Lőrincz, H.,
Szentpéteri, A.,
Tóth, N.,
Varga, É.,
Paragh, G.,
Harangi, M.:
Decreased Serum Stromal Cell-Derived Factor-1 in Patients with Familial Hypercholesterolemia and Its Strong Correlation with Lipoprotein Subfractions.
Int. J. Mol. Sci. 24 (20), 1-14, 2023.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
D1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2022
Németh, Á.,
Daróczy, B.,
Juhász, L.,
Fülöp, P.,
Harangi, M.,
Paragh, G.:
Assessment of associations between serum lipoprotein (a) levels and atherosclerotic vascular diseases in Hungarian patients with familial hypercholesterolemia using data mining and machine learning.
Front. Genet. 13 1-10, 2022.
Journal metrics:
Q2 Genetics
Q2 Genetics (clinical)
Q2 Molecular Medicine
Nádró, B.,
Lőrincz, H.,
Juhász, L.,
Szentpéteri, A.,
Sztanek, F.,
Varga, É.,
Páll, D.,
Paragh, G.,
Harangi, M.:
Determination of Serum Progranulin in Patients with Untreated Familial Hypercholesterolemia.
Biomedicines. 10 (4), 1-15, 2022.
Journal metrics:
Q2 Biochemistry, Genetics and Molecular Biology (miscellaneous)
Q1 Medicine (miscellaneous)
Madar, L.,
Juhász, L.,
Szűcs, Z.,
Kerkovits, L.,
Harangi, M.,
Balogh, I.:
Establishing the Mutational Spectrum of Hungarian Patients with Familial Hypercholesterolemia.
Genes. 13 (1), 1-13, 2022.
Journal metrics:
Q2 Genetics
Q2 Genetics (clinical)
Németh, Á.,
Harangi, M.,
Daróczy, B.,
Juhász, L.,
Paragh, G.,
Fülöp, P.:
Identifying Patients with Familial Chylomicronemia Syndrome Using FCS Score-Based Data Mining Methods.
J Clin Med. 11 1-14, 2022.
Journal metrics:
Q1 Medicine (miscellaneous)
Nádró, B.,
Lőrincz, H.,
Juhász, L.,
Szentpéteri, A.,
Sztanek, F.,
Seres, I.,
Páll, D.,
Fülöp, P.,
Paragh, G.,
Harangi, M.:
Serum progranulin level in patients with newly diagnosed untreated familial hypercholesterolemia.
Atherosclerosis. 355 e248, 2022.
Juhász, L.,
Lőrincz, H.,
Szentpéteri, A.,
Nádró, B.,
Varga, É.,
Paragh, G.,
Harangi, M.:
Sphingosine 1-Phosphate and Apolipoprotein M Levels and Their Correlations with Inflammatory Biomarkers in Patients with Untreated Familial Hypercholesterolemia.
Int. J. Mol. Sci. 23 1-12, 2022.
Journal metrics:
Q2 Catalysis
Q1 Computer Science Applications
D1 Inorganic Chemistry
Q1 Medicine (miscellaneous)
Q2 Molecular Biology
Q1 Organic Chemistry
Q1 Physical and Theoretical Chemistry
D1 Spectroscopy
2021
Harangi, M.,
Zsíros, N.,
Juhász, L.,
Nádró, B.,
Paragh, G.:
A lipoprotein(a) jelentősége az ateroszklerózis progressziójában.
Metabolizmus. 29 (2), 68-74, 2021.
Juhász, L.,
Nádró, B.,
Zsíros, N.,
Paragh, G.,
Harangi, M.:
Cardiovascular risk factors in newly diagnosed, untreated Hungarian patients with familial hypercholesterolemia.
Atherosclerosis. 331 e181, 2021.
Nádró, B.,
Juhász, L.,
Jalil, M.,
Balogh, I.,
Paragh, G.,
Harangi, M.:
Characterization of dyslipidemic patients with apolipoprotein E 2/2 genotype.
Atherosclerosis. 331 e181, 2021.
2020
Juhász, L.,
Balogh, I.,
Madar, L.,
Kovács, B.,
Harangi, M.:
A Rare Double Heterozygous Mutation in Low-Density Lipoprotein Receptor and Apolipoprotein B-100 Genes in a Severely Affected Familial Hypercholesterolaemia Patient.
Cureus. 12 (12), 1-5, 2020.
Juhász, L.,
Nádró, B.,
Zsíros, N.,
Paragh, G.,
Harangi, M.:
Kardiovaszkuláris kockázati tényezők előfordulási gyakorisága újonnan diagnosztizált familiáris hypercholesterinaemiás betegeinknél.
Metabolizmus. 18 (3), 174-180, 2020.
2018
Nádró, B.,
Juhász, L.,
Szentpéteri, A.,
Páll, D.,
Paragh, G.,
Harangi, M.:
Az apolipoprotein M és a szfingozin-1-foszfát tengely jelentősége az érelmeszesedés kialakulásának gátlásában.
Orvosi Hetilap. 159 (5), 168-175, 2018.
Journal metrics:
Q3 Medicine (miscellaneous)
Varga, V.,
Lőrincz, H.,
Szentpéteri, A.,
Juhász, L.,
Seres, I.,
Paragh, G.,
Balla, J.,
Paragh, G.,
Harangi, M.:
Changes in serum afamin and vitamin E levels after selective LDL apheresis.
J. Clin. Apheresis. 33 (5), 569-575, 2018.
Journal metrics:
Q2 Hematology
Q1 Medicine (miscellaneous)
2017
Harangi, M.,
Juhász, L.,
Nádró, B.,
Balla, J.,
Paragh, G.:
LDL apheresis or PCSK9 inhibition? Sometimes we have to combine them.
Vessel Plus. 1 91-95, 2017.
2014
2013
updated: 2024-10-06, 01:21